Cargando…
Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders
TP53 mutation status guides early therapeutic decisions in the treatment of clonal myeloid disorders and serves as a simple means of monitoring response to treatment. We aim here to develop a standardized protocol for evaluating TP53 mutation status in myeloid disorders using immunohistochemistry as...
Autores principales: | Rogers, Kai J., Abukhiran, Ibrahim M., Syrbu, Sergei, Tomasson, Michael, Bates, Melissa, Dhakal, Prajwal, Bhagavathi, Sharathkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031312/ https://www.ncbi.nlm.nih.gov/pubmed/36970330 http://dx.doi.org/10.1016/j.acpath.2022.100064 |
Ejemplares similares
-
Education Case: Hereditary Thrombophilia With Double Heterozygous Factor V Leiden and Factor II c.*97G>A Mutations
por: Abukhiran, Ibrahim, et al.
Publicado: (2021) -
Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations
por: Ibrahim, Abukhiran, et al.
Publicado: (2022) -
Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours
por: Abukhiran, Ibrahim A, et al.
Publicado: (2020) -
A Case of Secondary Hemophagocytic Lymphohistiocytosis Presenting with Severe Dyserythropoeisis in a Patient with Autoimmune Hemolysis
por: Rogers, Kai J., et al.
Publicado: (2022) -
A perspective on digital and computational pathology
por: Ramamurthy, Bhagavathi, et al.
Publicado: (2015)